Mortality Reduction Associated with Coexistent Antithrombotic Use in Nursing Home Residents with COVID-19.

Adler, Laurent; Lipton, Cathy; Watson, Clay C; Lawrence, Shanieek; Richie, Alexa; Spain, Clare; Heltemes, Kevin

Adler, Laurent; Lipton, Cathy; Watson, Clay C; Lawrence, Shanieek; Richie, Alexa; Spain, Clare; Heltemes, Kevin.

Adler L; Complex Care Management, Optum Inc, United Health Group, Eden Prairie, MN, USA.
Lipton C; Complex Care Management, Optum Inc, United Health Group, Eden Prairie, MN, USA.
Watson CC; Complex Care Management, Optum Inc, United Health Group, Eden Prairie, MN, USA.
Lawrence S; Optum Center for Research and Innovation, Optum Inc, UnitedHealth Group, Eden Prairie, MN, USA.
Richie A; Optum Center for Research and Innovation, Optum Inc, UnitedHealth Group, Eden Prairie, MN, USA.
Spain C; Health Care Economics, Optum Inc, United Health Group, Eden Prairie, MN, USA.
Heltemes K; Health Care Economics, Optum Inc, United Health Group, Eden Prairie, MN, USA.

J Am Med Dir Assoc ; 23(3): 440-441, 2022 Mar.

Article in English | MEDLINE | ID: covidwho-1521232

Subject(s)

COVID-19; Fibrinolytic Agents; Aged; Fibrinolytic Agents/therapeutic use; Homes for the Aged; Humans; Nursing Homes; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Fibrinolytic Agents / COVID-19 Limits: Aged / Humans Language: English Journal: J Am Med Dir Assoc Journal subject: History of Medicine / Medicine Year: 2022 Document Type: Article Affiliation country: J.jamda.2021.11.012

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google